Identification of sanguinarine metabolites in pig liver preparations by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 9, 2013, Pages 979-984

  Zhang, Hua Hai ^a   Wu, Yong ^b   Sun, Zhi Liang ^b   Liu, Zhao Ying ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b HUNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; BIOMOLECULES; BODY FLUIDS; ELECTROSPRAY IONIZATION; IONS; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; TRICHLOROACETIC ACID; VETERINARY MEDICINE;

ACCURATE MASS MEASUREMENTS; ANIMAL HUSBANDRY; CYTOSOLS; ION TRAPS; LIVER MICROSOMES; NATURAL COMPONENTS; PIG LIVER; SANGUINARINE; TIME OF FLIGHT MASS SPECTROMETRY; TRAP TIME;

METABOLITES;

EID: 84876244609     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6538     Document Type: Article

References (24)

1. G. B. Mahady, C. W. W. Beecher,. Quercetin-induced benzophenanthridine alkaloid production in suspension cell cultures of Sanguinaria canadensis. Planta Medica 1994, 60, 553.
2. C. Vavreckova, I. Gawlik, K. Muller,. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Medica 1996, 62, 397.
3. J. Lenfeld, M. Kroutil, E. Marsálek, J. Slavík, V. Preiniger, V. Simánek,. Antiinmmatory activity of quaternary benzophenanthridine alkaloids from Chelidonoum majus. Planta Medica 1981, 43, 161.
4. M. Sun, W. Lou, J. Y. Chun, D. S. Cho, N. Nadiminty, C. P. Evans, J. Chen, J. Yue, Q. Zhou, A. C. Gao,. Sanguinarine suppresses prostate tumor growth and inhibits surviving expression. Genes Cancer 2010, 1, 283.
5. I. Mackraj, T. Govender, P. Gathiram,. Sanguinarine. Cardiovasc. Ther. 2008, 26, 75.
6. N. Ahmad, S. Gupta, M. M. Husain, K. M. Heiskanen, H. Mukhtar,. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin. Cancer. Res. 2000, 6, 1524.
7. V. M. Adhami, M. H. Aziz, H. Mukhtar, N. Ahmad,. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer. Res. 2003, 9, 3176.
8. J. H. Jeng, H. L. Wu, B. R. Lin, W. H. Lan, H. H. Chang, Y. S. Ho, P. H. Lee, Y. J. Wang, J. S. Wang, Y. J. Chen, M. C. Chang,. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis 2007, 191, 250.
9. V. H. Frankos, D. J. Brusick, E. M. Johnson, H. I. Maibach, I. Munro, R.A. Squire, C.S. Weil,. Safety of sanguinaria extract as used in commercial toothpaste and oral rinse products. J. Can. Dent. Assoc. 1990, 56, S41.
10. P. Kosina, D. Walterova, J. Ulrichova, V. Lichnovsky, M. Stiborova, H. Rydlova, J. Vicar, V. Krecman, M. J. Brabec, V. Simanek,. Sanguinarine and chelerythrine: assessment of safety on pigs in ninety days feeding experiment. Food Chem. Toxicol. 2004, 42, 85.
11. S. A. Hakim, V. Mijovic, J. Walker,. Experimental transmission of sanguinarine in milk: Detection of a metabolic product. Nature 1961, 189, 201.
12. S. Tandon, M. Das, S. K. Khanna,. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. Drug Metab. Dispos. 1993, 21, 194.
13. J. Psotova, B. Klejdus, R. Vecera, P. Kosina, V. Kuban, J. Vicar, V. Simanek, J. Ulrichova,. A liquid chromatographic-mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in rat. J. Chromatogr. B 2006, 830, 165.
14. R. Vecera, B. Klejdus, P. Kosina, J. Orolin, M. Stiborova, S. Smrcek, J. Vicar, Z. Dvorak, J. Ulrichova, V. Kuban,. Disposition of sanguinarine in the rat. Xenobiotica 2007, 37, 549.
15. Z. Dvorak, V. Simanek,. Metabolism of sanguinarine: the facts and the myths. Curr. Drug Metab. 2007, 8, 173.
16. A. Deroussent, M. Re, H. Hoellinger, T. Cresteil,. Metabolism of sanguinarine in human and in rat: Characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52, 391.
17. P. Kosina, J. Vacek, B. Papouskova, M. Stiborova, J. Styskala, P. Cankar, E. Vrublova, J. Vostalova, V. Simanek, J. Ulrichova,. Identification of benzo[c]phenanthridine metabolites in human hepatocytes by liquid chromatography with electrospray ion-trap and quadrupole time-of-flight mass spectrometry. J. Chromatogr. B 2011, 879, 1077.
18. J. Dostal, M. Potacek,. Quaternary benzo[c]phenanthridine alkaloids. Collect. Czech. Chem. Commun. 1990, 55, 2840.
19. M. Janovska, M. Kubala, V. Simánek, J. Ulrichova,. Fluorescence of sanguinarine: fundamental characteristics and analysis of interconversion between various forms. Anal. Bioanal. Chem. 2009, 395, 235.
20. Z. Liu, L. Huang, M. Dai, D. Chen, Y. Tao, Y. Wang, Z. Yuan,. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of- flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 2026.
21. n information and accurate mass measurements. J. Pharm. Biomed. Anal. 2009, 50, 1022.
22. Z. Y. Liu, L. L. Huang, D. M. Chen, M.H. Dai, Y. F. Tao, Y. L. Wang, Z. H. Yuan,. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro. Anal. Bioanal. Chem. 2010, 396, 1259.
23. Z. Y. Liu,. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies. J. Mass Spectrom. 2012, 47, 1627.
24. C. D. Goodwin, S. Margolis,. Improved methods for the study of hepatic HMG CoA reductase: one-step isolation of mevalonolactone and rapid preparation of endoplasmic reticulum. J. Lipid Res. 1976, 17, 297.